Aveanna Healthcare (NASDAQ:AVAH) CEO Jeff Shaner Sells 29,357 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $7.85, for a total transaction of $230,452.45. Following the sale, the chief executive officer owned 2,394,179 shares in the company, valued at approximately $18,794,305.15. This trade represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Jeff Shaner also recently made the following trade(s):

• On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total transaction of $226,373.32.
• On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total value of $233,486.44.

Aveanna Healthcare Trading Down 1.1%

AVAH stock opened at $8.08 on Friday. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The firm has a market cap of $1.69 billion, a P/E ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 1-year low of $3.67 and a 1-year high of $10.32. The business’s 50 day moving average is $8.92 and its 200-day moving average is $7.49.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The firm had revenue of $450.53 million for the quarter. Equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on AVAH shares. Truist Financial lifted their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a report on Friday, November 7th. BMO Capital Markets assumed coverage on shares of Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 target price for the company. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. Royal Bank Of Canada raised their price target on Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, October 24th. Finally, UBS Group lifted their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research report on Friday, November 7th. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $10.69.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of AVAH. Summit Partners L P acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at $50,477,000. AustralianSuper Pty Ltd acquired a new position in shares of Aveanna Healthcare during the third quarter valued at $15,743,000. Vanguard Group Inc. boosted its holdings in Aveanna Healthcare by 34.7% in the third quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock valued at $35,850,000 after acquiring an additional 1,041,324 shares during the last quarter. Hillsdale Investment Management Inc. acquired a new stake in Aveanna Healthcare in the third quarter worth about $7,922,000. Finally, Assenagon Asset Management S.A. bought a new stake in Aveanna Healthcare during the 3rd quarter worth about $7,356,000. 87.96% of the stock is currently owned by institutional investors.

Key Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.